Stuart Barnscher

Senior Director, Preclinical Programs, ADC Therapeutic Development Zymeworks

Seminars

Wednesday 5th November 2025
Spotlighting Development & Therapeutic Potential of ZW327: a Novel Ly6E Targeting ADC Against Solid Tumors
3:00 pm
  • Exploring target characteristics, solid tumor expressions rationale for re-exploring Ly6E as a novel ADC target 
  • Showcasing design and development of ZW327 across anti-Ly6E antibody generation paired with novel topo1 payload 
  • Exploring preliminary findings and future development plans for ZW327 across solid tumor indications

Stuart Barnscher
View all Speakers
View Event Brochure